One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma
One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma
This non-interventional retrospective study aims to describe the therapeutic procedures and
 modalities received by patients and the correlation to hormone status, during a one year
 follow up from completion of the 2-79-52030-207 study.
Inclusion Criteria:

 -  Completed the 2-79-52030-207 study and received 12 injections of lanreotide Autogel
 120 mg, regardless of efficacy at the end of this period.

 -  Subject or in case of subject's death next of kin having given their written informed
 consent prior to collection of the data by the sponsor (if locally required)